Skip to main content
Công ty Cổ phần Dược phẩm Imexpharm logo

Công ty Cổ phần Dược phẩm Imexpharm — Investor Relations & Filings

Ticker · IMP ISIN · VN000000IMP0 HSX Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2022-12-22 Director's Dealing
Country VN Viet Nam
Listing HSX IMP

About Công ty Cổ phần Dược phẩm Imexpharm

www.imexpharm.com

Imexpharm Corporation is a prominent pharmaceutical company with over 48 years of experience in the manufacturing, compounding, and distribution of high-quality pharmaceutical products. The company operates extensive production facilities, including three EU-GMP certified factory clusters and one WHO-GMP certified cluster, making it a leader in EU-GMP compliant manufacturing. Imexpharm is recognized as a top producer of antibiotics and offers a diverse product portfolio encompassing injectable and oral antibiotics, cardiovascular, ophthalmic, musculoskeletal, respiratory, and digestive system treatments, alongside vitamins, minerals, and health protection foods. With 28 product registrations for 11 products in Europe, Imexpharm is dedicated to delivering effective and safe healthcare solutions to the community.

Recent filings

Filing Released Lang Actions
IMP: Kết quả giao dịch cổ phiếu của NNB và NCLQ - CTCP Đầu tư Bình Minh Kim
Director's Dealing Classification · 98% confidence The document is a formal “Báo cáo kết quả giao dịch cổ phiếu của người nội bộ và người có liên quan” (report on share transactions by insiders and their related persons), filed with the State Securities Commission and stock exchange. It details individual insider transactions—quantities bought, held before/after, method, timing—matching the definition of an insider trading report. This falls under Director’s Dealing (insider personal share transactions).
2022-12-22 Vietnamese
IMP: Thông báo giao dịch cổ phiếu của NNB và NCLQ - CTCP Đầu tư Bình Minh Kim
Director's Dealing Classification · 91% confidence The document is a formal notice disclosing share transactions by insiders (internal persons) and affiliated persons, detailing the number of shares held before and after, percentages, transaction method, and timing. It is not a corporate buyback but an insider dealing disclosure, matching the definition for Director's Dealing (DIRS).
2022-12-22 Vietnamese
IMP: Nghị quyết HĐQT về việc sử dụng quỹ đầu tư phát triển bù đắp chi phí hoạt động năm 2022
Regulatory Filings Classification · 85% confidence The document is a Vietnamese regulatory disclosure to the State Securities Commission and the Ho Chi Minh Stock Exchange, announcing a Board of Directors’ resolution dated November 29, 2022, regarding the use of the company’s development fund to cover operating costs. It does not contain actual financial statements, an earnings summary, or a report itself, nor is it announcing a change in board composition. It is a compliance/announcement filing that does not fit any of the specialized report categories, so it defaults to Regulatory Filings (RNS).
2022-11-30 Vietnamese
IMP: Báo cáo kết quả giao dịch cổ phiếu của người nội bộ Trần Hoài Hạnh (điều chỉnh)
Director's Dealing Classification · 98% confidence The document is a formal report detailing an insider’s share transactions (name of insider, security code, number of shares bought/sold, percentages before and after, transaction method and dates). It matches the definition of "Director's Dealing" (reports of personal share transactions by company directors and executives).
2022-11-23 Vietnamese
IMP: Báo cáo kết quả giao dịch cổ phiếu của Người nội bộ Trần Hoài Hạnh
Director's Dealing Classification · 92% confidence The document is a Vietnamese form titled “Báo cáo kết quả giao dịch cổ phiếu/chứng chỉ quỹ của người nội bộ…,” which translates to a report on transactions in shares/fund certificates by insiders (internal persons of the public company). It details the individual insider’s identity, position, share code (IMP), number of shares bought/sold before and after, transaction method and period. This is precisely an insider personal share transaction report, matching ‘Director’s Dealing’ (insider trades).
2022-11-16 Vietnamese
IMP: Thông báo giao dịch cổ phiếu của tổ chức có liên quan đến người nội bộ CTCP Đầu tư Bình Minh Kim
Director's Dealing Classification · 95% confidence The document is a formal insider trading disclosure titled “NOTICE OF TRANSACTION IN SHARES OF INTERNAL PERSON AND AFFILIATED PERSON OF INTERNAL PERSON.” It details share transactions by insiders and their related parties, including number of shares before and after, transaction method, and timing. This corresponds to insider/director dealings reporting requirements. Therefore, it is a Director's Dealing report.
2022-11-16 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.